Gabriela Möslein

Chair, European Hereditary Tumour Group (EHTG), and
Past-General-Secretary, European Society of Coloproctology (ESCP)

Professor Moeslein is Professor of Surgery and Dept. Head of the newly established Center for Hereditary Tumors at the Academic Hospital of the University of Düsseldorf Ev. BETHESDA in Duisburg, Germany.

She completed her surgical training at the University of Heidelberg and Düsseldorf, interrupted by a 6 month stipend at the University of Hyogo, where she trained with Prof. Joji Utsonomiya. Further she completed her research year with a DFG-funded stipend to Mayo Clinic, Dept. of Molecular Genetics headed by Prof. Steve Thibodeau. She was chair of the Surgical Dept. at HELIOS St. Josefs-Klinik in Bochum, before she transitioned to the more specialized and dedicated Surgical Center for Hereditary Tumors at the University of Witten-Herdecke in 2015. Here she dedicated most of her surgeries to the field of prophylactic surgery for hereditary conditions, ileoanal and continent pouches (Kock Pouch) and also incontinence surgery. The dedicated center and concept transitioned to the Academic Hospital of the University of Düsseldorf BETHESDA Khs. Duisburg in January 2020.

Prof. Moeslein has been a long-standing elected Council member and Director of InSiGHT (International Society for Hereditary Gastrointestinal Tumors) and hosted the biennial meeting in 2009 in Düsseldorf. Together with Prof. H. Vasen she initiated and chaired the Mallorca Group as a European Expert Group on Hereditary Cancer. This group was reformed to the Society of Hereditary Tumors in 2016. She is external advisor of for the CFR (Cancer Family Registries) and is a founding member of the IMRC (International Mismatch Repair Consortium). She is also a founding member of the German Consortium for HNPCC and Steering Committee member. She leads the working group on Hereditary Gastrointestinal Cancer of the German Society of Visceral Surgeons. She was Secretary of ESCP (European Society for Coloproctology) from 2016 – 2020 and is now Program Director. Her research activities focus on prophylactic surgery for hereditary conditions, ileoanal and continent pouches  and chemoprevention. She focusses on promoting and enabling collaborative studies and networking and more than 200 peer reviewed publications and book chapters.

Updated: November 2021